Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

References

Page 1

	Year	Citations
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Howard A. Burris, Malcolm J. Moore, John Sahl Andersen, Journal of Clinical Oncology	1997	5.8K
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells James R. Bischoff, David H. Kirn, Angelica Williams, Science Mutant AdenovirusAdenovirus MutantFunctional P53Mutant AdenovirusesMedicine	1996	1.8K
ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways Yanping Zhang, Yue Xiong, Wendell G. Yarbrough Cell Tumor BiologyCell RegulationMedicineCancer Cell BiologyProtein Degradation	1998	1.6K
Cancer: Principles and Practice of Oncology Walter G. Gunn JAMA Preclinical TherapeuticsSurgical OncologyCancer ManagementEpidemiology Of CancerClinical Specialties	1997	1.3K
A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Fadlo R. Khuri, John Nemunaitis, Ian Ganly, Nature Medicine Intratumoral Onyx-015Neck CancerMedicinePathologyHead And Neck Cancer	2000	1.1K
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Carla Heise, Adam Sampson-Johannes, Angelica Williams, Nature Medicine Tumor BiologyCancer-associated VirusOncogenic AgentMedicineTumor-specific Cytolysis	1997	944
[Cancer of the pancreas]. Badell Urdaneta A PubMed Surgical OncologyPancreatic CancerMedicineSurgical PathologyHistopathology	1972	632
Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. John F. Engelhardt, X Ye, B Doranz, Proceedings of the National Academy of Sciences Viral ReplicationImmunologyPathologyImmunotherapyTransgene Persistence	1994	624
p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Fredrick S. Leach, Takashi Tokino, Paul S. Meltzer, PubMed PathologyCancer BiologyTumor BiologyCancer Cell BiologyMolecular Oncology	1993	538
Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy Jonas Bergh, Torbjörn Norberg, Sigrid Sjögren, Nature Medicine Breast OncologyBreast Cancer PatientsP53 GeneMedicinePathology	1995	459

Page 1